These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1892080

  • 21. Encainide for resistant supraventricular tachycardia in children: follow-up report.
    Strasburger JF, Smith RT, Moak JP, Gothing C, Garson A.
    Am J Cardiol; 1988 Dec 20; 62(19):50L-54L. PubMed ID: 3144168
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH, Kunze KP, Schlüter M, Duckeck W.
    Am J Cardiol; 1988 Dec 20; 62(19):37L-44L. PubMed ID: 3144166
    [Abstract] [Full Text] [Related]

  • 24. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP.
    Am J Cardiol; 1998 Oct 16; 82(8A):59N-65N. PubMed ID: 9809902
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X, Zhang Y, Liu H, Jiang H, Ge H, Zhang Y.
    Am J Cardiol; 2017 May 01; 119(9):1366-1370. PubMed ID: 28283175
    [Abstract] [Full Text] [Related]

  • 26. [Propafenon therapy of arrhythmias in infancy and childhood (author's transl)].
    Weber H, Eigster G, Wesselhoeft H.
    Monatsschr Kinderheilkd; 1981 Jul 01; 129(7):410-3. PubMed ID: 6167855
    [Abstract] [Full Text] [Related]

  • 27. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 01; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 28. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
    Paul T, Lehmann C, Pfammatter JP, Kallfelz HC.
    Z Kardiol; 1994 Dec 01; 83(12):891-7. PubMed ID: 7531374
    [Abstract] [Full Text] [Related]

  • 29. Oral propafenone as treatment for incessant supraventricular and ventricular tachycardia in children.
    Beaufort-Krol GC, Bink-Boelkens MT.
    Am J Cardiol; 1993 Nov 15; 72(15):1213-4. PubMed ID: 8237821
    [No Abstract] [Full Text] [Related]

  • 30. [Use of propafenone in emergency therapy].
    Liguori A, Pellegrino G, Di Ieso N, Piatto A, Ruggiero P, Scarnera P, Guardascione A.
    Clin Ter; 1989 Dec 15; 131(5):307-14. PubMed ID: 2532584
    [Abstract] [Full Text] [Related]

  • 31. Propafenone in Wolff-Parkinson-White syndrome at risk.
    Santinelli V, Turco P, De Paola M, Smimmo D, Giasi M, Santinelli C, Chiariello M, Condorelli M.
    Cardiovasc Drugs Ther; 1990 Jun 15; 4(3):681-5. PubMed ID: 2076378
    [Abstract] [Full Text] [Related]

  • 32. Paroxysmal supraventricular tachycardia: experience with propafenone.
    Santinelli V, De Paola M, Turco P, Smimmo D, Chiariello M.
    Angiology; 1989 Jun 15; 40(6):563-8. PubMed ID: 2719341
    [Abstract] [Full Text] [Related]

  • 33. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation].
    Fauchier JP, Cosnay P, Moquet B, Rouesnel P, Kapusta P, Vrancea F.
    Arch Mal Coeur Vaiss; 1986 Sep 15; 79(10):1506-14. PubMed ID: 3099684
    [Abstract] [Full Text] [Related]

  • 34. Oral propafenone therapy for patients with paroxysmal supraventricular tachyarrhythmia.
    Allen BJ, Brodsky MA, Doria R, Luckett CR, Thomas R, Henry WL.
    Chest; 1988 Oct 15; 94(4):853-4. PubMed ID: 3168580
    [No Abstract] [Full Text] [Related]

  • 35. [Electrophysiologic effect of intravenous propafenone in supraventricular tachycardia].
    Iturralde P, Nunura F, Romero L, Colín L, Rosado J, Galván O, de Micheli A, González Hermosillo JA, Casanova JM.
    Arch Inst Cardiol Mex; 1991 Oct 15; 61(2):135-41. PubMed ID: 1854228
    [Abstract] [Full Text] [Related]

  • 36. Electrophysiologic effects and efficacy of intravenous propafenone in terminating atrioventricular reentrant tachycardia in children.
    Hessling G, Brockmeier K, Ruediger HJ, Ulmer HE.
    Am J Cardiol; 2001 Mar 15; 87(6):802-4, A9. PubMed ID: 11249911
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H, Baker BJ, de Soyza N, Murphy ML.
    Am Heart J; 1988 Jan 15; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [Abstract] [Full Text] [Related]

  • 39. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM, Palmer KJ, Langtry HD, Fitton A.
    Drugs; 1993 Jan 15; 45(1):85-130. PubMed ID: 7680987
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.